Literature DB >> 24403470

Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck.

Waleed F Mourad1, Kenneth S Hu, Daniel Shasha, Catherine Concert, Dan Ishihara, Wilson Lin, Rania A Shourbaji, Magdalena Ryniak, Mauricio E Gamez, John N Lukens, Zujun Li, Bruce E Culliney, Azita S Khorsandi, Theresa Tran, Adam Jacobson, Spiros Manolidis, Stimson Schantz, Mark Urken, Mark S Persky, Louis B Harrison.   

Abstract

AIM: Metastasis of unknown primary (MUP) is commonly treated with radiation therapy (RT) to the entire mucosal surfaces and bilateral neck nodes (LN). We report outcomes of oropharynx-targeted RT, retropharyngeal nodes (RPN) and bilateral LN in this context. PATIENTS AND METHODS: Single-Institution retrospective study of 68 patients. Forty percent were treated with intensity-modulated radiation therapy (IMRT). Fifty-six percent received concurrent chemoradiotherapy (CCRT). The median age was 58 years, 82% were Caucasian, and 75% males. Stage III disease was present in 9%, stage IVA in 75% and IVB in 16%.
RESULTS: At a median follow-up of 3.5 years, the actuarial locoregional control was 95.5%. The emergence of primary developed in 1patient (1.5%) and 2patients (3%) failed in the neck. The median time-to-locoregional failure (LRF) was 18 months. Actuarial long-term RT toxicity was grade 1 xerostomia (68%), dysphagia (35%), neck stiffness (15%) and trismus (6%).
CONCLUSION: RT to the oropharynx, RPN, and bilateral neck provides excellent oncological and functional outcomes in MUP in non-Asian patients. Sparing the mucosal surfaces of the nasopharynx, hypopharynx, and larynx seems reasonable without impacting on survival and locoregional control.

Entities:  

Keywords:  Metastatic unknown primary cancer squamous cell carcinoma; oropharynx-targeted radiation therapy concurrent chemoradiotherapy

Mesh:

Year:  2014        PMID: 24403470

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Factors Influencing the Outcome of Head and Neck Cancer of Unknown Primary (HNCUP).

Authors:  Matthias Balk; Robin Rupp; Konstantinos Mantsopoulos; Matti Sievert; Magdalena Gostian; Moritz Allner; Philipp Grundtner; Markus Eckstein; Heinrich Iro; Markus Hecht; Antoniu-Oreste Gostian
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

2.  Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.

Authors:  Mária Gődény; Zsolt Lengyel; Gábor Polony; Zoltán Takácsi Nagy; Gergely Léránt; Orsolya Zámbó; Éva Remenár; László Tamás; Miklós Kásler
Journal:  Cancer Imaging       Date:  2016-11-04       Impact factor: 3.909

Review 3.  Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.

Authors:  Jens Müller von der Grün; Aykut Tahtali; Shahram Ghanaati; Claus Rödel; Panagiotis Balermpas
Journal:  Radiat Oncol       Date:  2017-05-10       Impact factor: 3.481

Review 4.  Updates in the management of unknown primary of the head and neck.

Authors:  Sandhya Kalavacherla; Parag Sanghvi; Grace Y Lin; Theresa Guo
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

5.  Tailored multimodality therapy guided by a two-step decision making process for head-and-neck cancer of unknown primary.

Authors:  Shengjin Dou; Wei Qian; Qinghai Ji; Zhuoying Wang; Guopei Zhu
Journal:  Oncotarget       Date:  2016-06-28

6.  Long-term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study.

Authors:  Shengjin Dou; Rongrong Li; Lin Zhang; Zhuoying Wang; Li Xie; Chenping Zhang; Guopei Zhu
Journal:  Cancer Med       Date:  2020-01-17       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.